Summit Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $79.5M | $66.4M |
| FY2021 | — | $83.3M | $71.8M |
| FY2022 | — | $126.7M | $348.6M |
| FY2023 | — | $77.7M | $71.4M |
| FY2024 | — | $388.7M | $104.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $79.5M | $66.4M |
| FY2021 | — | $83.3M | $71.8M |
| FY2022 | — | $126.7M | $348.6M |
| FY2023 | — | $77.7M | $71.4M |
| FY2024 | — | $388.7M | $104.9M |